Literature DB >> 10457044

Functional bowel disorders and functional abdominal pain.

W G Thompson1, G F Longstreth, D A Drossman, K W Heaton, E J Irvine, S A Müller-Lissner.   

Abstract

The Rome diagnostic criteria for the functional bowel disorders and functional abdominal pain are used widely in research and practice. A committee consensus approach, including criticism from multinational expert reviewers, was used to revise the diagnostic criteria and update diagnosis and treatment recommendations, based on research results. The terminology was clarified and the diagnostic criteria and management recommendations were revised. A functional bowel disorder (FBD) is diagnosed by characteristic symptoms for at least 12 weeks during the preceding 12 months in the absence of a structural or biochemical explanation. The irritable bowel syndrome, functional abdominal bloating, functional constipation, and functional diarrhea are distinguished by symptom-based diagnostic criteria. Unspecified FBD lacks criteria for the other FBDs. Diagnostic testing is individualized, depending on patient age, primary symptom characteristics, and other clinical and laboratory features. Functional abdominal pain (FAP) is defined as either the FAP syndrome, which requires at least six months of pain with poor relation to gut function and loss of daily activities, or unspecified FAP, which lacks criteria for the FAP syndrome. An organic cause for the pain must be excluded, but aspects of the patient's pain behavior are of primary importance. Treatment of the FBDs relies upon confident diagnosis, explanation, and reassurance. Diet alteration, drug treatment, and psychotherapy may be beneficial, depending on the symptoms and psychological features.

Entities:  

Mesh:

Year:  1999        PMID: 10457044      PMCID: PMC1766683          DOI: 10.1136/gut.45.2008.ii43

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

Review 1.  Irritable bowel syndrome. Diagnosis in the managed care era.

Authors:  G F Longstreth
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

Review 2.  Chronic functional abdominal pain.

Authors:  D A Drossman
Journal:  Am J Gastroenterol       Date:  1996-11       Impact factor: 10.864

3.  Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples.

Authors:  W E Whitehead; M D Crowell; L Bosmajian; A Zonderman; P T Costa; C Benjamin; J C Robinson; B R Heller; M M Schuster
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

4.  A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease.

Authors:  W Kruis; C Thieme; M Weinzierl; P Schüssler; J Holl; W Paulus
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

5.  Prognosis in the irritable bowel syndrome: a 5-year prospective study.

Authors:  R F Harvey; E C Mauad; A M Brown
Journal:  Lancet       Date:  1987-04-25       Impact factor: 79.321

Review 6.  Irritable bowel syndrome and chronic pelvic pain.

Authors:  G F Longstreth
Journal:  Obstet Gynecol Surv       Date:  1994-07       Impact factor: 2.347

7.  Gender differences in irritable bowel symptoms.

Authors:  W G Thompson
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-03       Impact factor: 2.566

8.  Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome.

Authors:  C S Probert; P M Emmett; H A Cripps; K W Heaton
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

9.  Polyethylene glycol 4000 for slow transit constipation.

Authors:  A G Klauser; B E Mühldorfer; W A Voderholzer; G Wenzel; S A Müller-Lissner
Journal:  Z Gastroenterol       Date:  1995-01       Impact factor: 2.000

10.  A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance.

Authors:  F L Suarez; D A Savaiano; M D Levitt
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

View more
  409 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Effectiveness of laxatives in adults.

Authors:  M Petticrew; M Rodgers; A Booth
Journal:  Qual Health Care       Date:  2001-12

3.  Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997.

Authors:  Jennifer Hollowell; Annika Lundgren; Saga Johansson
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

4.  Healing Words: Using Affect Labeling to Reduce the Effects of Unpleasant Cues on Symptom Reporting in IBS Patients.

Authors:  Elena Constantinou; Katleen Bogaerts; Lukas Van Oudenhove; Jan Tack; Ilse Van Diest; Omer Van den Bergh
Journal:  Int J Behav Med       Date:  2015-08

Review 5.  Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation.

Authors:  Pierre Paré; Richard N Fedorak
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

6.  Irritable Bowel Syndrome: Bacterial Overgrowth--What's Known and What to Do.

Authors:  Mark Pimentel; Sheila Lezcano
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

7.  Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring.

Authors:  J H Winston; Q Li; S K Sarna
Journal:  Neurogastroenterol Motil       Date:  2014-03-04       Impact factor: 3.598

8.  Cerebral processing of auditory stimuli in patients with irritable bowel syndrome.

Authors:  Viola Andresen; Alexander Poellinger; Chedwa Tsrouya; Dominik Bach; Albrecht Stroh; Annette Foerschler; Petra Georgiewa; Marco Schmidtmann; Ivo R van der Voort; Peter Kobelt; Claus Zimmer; Bertram Wiedenmann; Burghard F Klapp; Hubert Monnikes
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 9.  Restriction of FODMAP in the management of bloating in irritable bowel syndrome.

Authors:  Wei Mon Wong
Journal:  Singapore Med J       Date:  2016-09       Impact factor: 1.858

10.  Autonomic function at rest and in response to emotional and rectal stimuli in women with irritable bowel syndrome.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.